MedPath

Comparative Clinical Trial of Lornoxicam to Diclofenac in Patients of Osteoarthritis of Knee Joint.

Not Applicable
Completed
Conditions
Osteoarthritis of Knee Joint
Interventions
Registration Number
NCT01055470
Lead Sponsor
Government Medical College, Bhavnagar
Brief Summary

The purpose of this study was to compare the pain relieving action of the lornoxicam and diclofenac in patients of OA knee.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Newly diagnosed patient aged between 25 to 65 yrs of either gender suffering from osteoarthritis of knee according to criteria given by American College of Rheumatology
  • Informed consent obtained from the patient.
Exclusion Criteria
  • Patients with any other systemic llness,
  • Patients with pregnancy and lactation,
  • Patients taking other drugs like lithium[4], digoxin, methotrexate, anticoagulants, antidiabetics, diuretics,
  • Patients with H/O hypersensitivity to NSAIDs,
  • Patients who had consumed any analgesics in last 1 month

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
LornoxicamLornoxicamTab. Lornoxicam 4 mg , orally, 8 hourly after taking food in morning , in noon and evening for 3 months.
DiclofenacDiclofenacTab.Diclofenac 50 mg ,Orally, 12 hrly in morning and in evening after taking food for 3 months.
Primary Outcome Measures
NameTimeMethod
Difference in reduction in reading of Wong Baker face pain scale and in time of 100 meters walking test3 months
Secondary Outcome Measures
NameTimeMethod
To monitor side effects of study drugs.3 months

Trial Locations

Locations (1)

Sir Takthasinhji General Hospital

🇮🇳

Bhavnagar, Gujarat, India

© Copyright 2025. All Rights Reserved by MedPath